Anlon Healthcare Ltd vs Emmessar Biotech Nutrition Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 114.45 as of 23 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Emmessar Biotech & Nutrition Ltd changed from 5.1 on March 2021 to 48.2 on March 2025 . This represents a CAGR of 56.71% over 5 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Emmessar Biotech & Nutrition Ltd changed from ₹ 7.35 crore on March 2021 to ₹ 15.2 crore on March 2025 . This represents a CAGR of 15.64% over 5 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 35.78 crore as compare to the Sep '25 revenue of ₹ 52.23 crore. This represent the decline of -31.5% The revenue of Emmessar Biotech & Nutrition Ltd for the Dec '25 is ₹ 0.58 crore as compare to the Sep '25 revenue of ₹ 0.63 crore. This represent the decline of -7.94% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 12.54 crore as compare to the Sep '25 ebitda of ₹ 13.77 crore. This represent the decline of -8.93% The ebitda of Emmessar Biotech & Nutrition Ltd for the Dec '25 is ₹ 0.15 crore as compare to the Sep '25 ebitda of ₹ 0.17 crore. This represent the decline of -11.76% The net profit of Anlon Healthcare Ltd changed from ₹ 4.54 crore to ₹ 5.15 crore over 7 quarters. This represents a CAGR of 7.47% The net profit of Emmessar Biotech & Nutrition Ltd changed from ₹ 0.09 crore to ₹ 0.12 crore over 7 quarters. This represents a CAGR of 17.87% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Emmessar Biotech & Nutrition Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Emmessar Biotech & Nutrition Ltd

Emmessar Biotech & Nutrition Limited (EBNL), originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals.
The Company has so far, succeeded in developing many Specialty Fine Chemicals.
ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996.
To better represent its new core activity, a change in the Company name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, was made essential. On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated.

FAQs for the comparison of Anlon Healthcare Ltd and Emmessar Biotech & Nutrition Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Emmessar Biotech & Nutrition Ltd?

Market cap of Anlon Healthcare Ltd is 644 Cr while Market cap of Emmessar Biotech & Nutrition Ltd is 12 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Emmessar Biotech & Nutrition Ltd?

The stock performance of Anlon Healthcare Ltd and Emmessar Biotech & Nutrition Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Emmessar Biotech & Nutrition Ltd?

As of March 23, 2026, the Anlon Healthcare Ltd stock price is INR ₹121.35. On the other hand, Emmessar Biotech & Nutrition Ltd stock price is INR ₹24.34.

How do dividend payouts of Anlon Healthcare Ltd and Emmessar Biotech & Nutrition Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Emmessar Biotech & Nutrition Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.